| 发明名称 |
produto de combinação farmacêutica, e, inalador de pó seco. |
| 摘要 |
The present invention is directed to the combination of a muscarinic receptor antagonist and a corticosteroid, and the use of said combination in treating diseases mediated via the M3 muscarinic acetylcholine receptor and/or the glucocorticoid receptor, such as asthma. |
| 申请公布号 |
BR112013031572(A2) |
申请公布日期 |
2017.03.21 |
| 申请号 |
BR20131131572 |
申请日期 |
2012.06.01 |
| 申请人 |
GLAXO GROUP LIMITED |
发明人 |
GLENN CRATER |
| 分类号 |
A61K31/58;A61K31/138;A61K31/439;A61K45/06;A61P11/06;A61P11/08 |
主分类号 |
A61K31/58 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
